CrossrefInfokarte
Galectins and the Interleukin-33/Suppression of Tumorigenicity-2 Pathway in First-episode Psychosis and Schizophrenia: A Cross-sectional Exploratory Study
Clinical Psychopharmacology and Neuroscience · 2026-11-30 · 24 (4) · 844-853
DOI: 10.9758/cpn.26.1429 ↗Abstract
Kein Abstract verfügbar.
EUVIMED